Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunityFranziska S Hoffmann, Peer-Hendrik Kuhn, Sarah A Laurent, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2020
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and GermanyJia Liu, Masahiro Mori, Hanna Zimmermann, et al.
Cell Reports. Medicine|May 19, 2026
Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxiaSamantha Ho, Hoi Kiu Wong, Dorina Shqau, et al.
Annals of Neurology|July 18, 2018
Pathogenicity of human antibodies against myelin oligodendrocyte glycoproteinMelania Spadaro, Stephan Winklmeier, Eduardo Beltrán, et al.
Nature Communications|June 13, 2015
γ-Secretase directly sheds the survival receptor BCMA from plasma cellsSarah A Laurent, Franziska S Hoffmann, Peer-Hendrik Kuhn, et al.
Brain : a Journal of Neurology|November 8, 2022
Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damageLuise Appeltshauser, Helena Junghof, Julia Messinger, et al.
Therapeutic Advances in Neurological Disorders|December 12, 2023
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment responseValerie E Teschner, Ann-Katrin Fleck, Carolin Walter, et al.
Nature|February 28, 2014
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseasesPing Shen, Toralf Roch, Vicky Lampropoulou, et al.
Acta Neuropathologica Communications|December 1, 2020
Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNSRamona Gerhards, Lena Kristina Pfeffer, Jessica Lorenz, et al.
Pageof 12